5月28日 - ** 医疗设备制造商波士顿科学BSX.N股价盘前下跌2%至103美元
** 波士顿科学公司（BSX）表示， (link)，该公司将停止在全球范围内销售其实验性心脏设备，并不再寻求美国食品和药物管理局（FDA）在该国或其他地区的批准。
** 该公司称，做出这一决定是由于监管要求的提高
** 该公司还表示，预计第二季度和 25 财年的销售额和调整后盈利将达到预期。
** 截至上次收盘，股价累计上涨约 19
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.